Sorrento Therape Stock EBITDA

SRNE Stock  USD 0  0.0005  16.67%   
Sorrento Therape fundamentals help investors to digest information that contributes to Sorrento Therape's financial success or failures. It also enables traders to predict the movement of Sorrento OTC Stock. The fundamental analysis module provides a way to measure Sorrento Therape's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sorrento Therape otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sorrento Therape OTC Stock EBITDA Analysis

Sorrento Therape's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Sorrento Therape EBITDA

    
  (364.52 M)  
Most of Sorrento Therape's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sorrento Therape is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Sorrento Therape reported earnings before interest,tax, depreciation and amortization of (364.52 Million). This is 141.54% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 109.35% higher than that of the company.

Sorrento EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sorrento Therape's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Sorrento Therape could also be used in its relative valuation, which is a method of valuing Sorrento Therape by comparing valuation metrics of similar companies.
Sorrento Therape is currently under evaluation in ebitda category among its peers.

Sorrento Fundamentals

About Sorrento Therape Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sorrento Therape's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sorrento Therape using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sorrento Therape based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Sorrento OTC Stock

Sorrento Therape financial ratios help investors to determine whether Sorrento OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sorrento with respect to the benefits of owning Sorrento Therape security.